Giulia Cattaneo

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Marco Ventin · 2 shared papers, 2024–2026 · strength 0.50
   • Paper Implications of Homologous Recombination Deficiency for Neoadjuvant Platinum-Based Chemotherapy in Pancreatic Cancer: A… DOI 10.1245/s10434-025-19056-0↗
   • Paper Interplay between B7-H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2024.216713↗
2. Luigi Liguori · 1 shared paper, 2026 · strength 0.33
   • Paper Implications of Homologous Recombination Deficiency for Neoadjuvant Platinum-Based Chemotherapy in Pancreatic Cancer: A… DOI 10.1245/s10434-025-19056-0↗
3. Cristina Rosa Ferrone · 1 shared paper, 2026 · strength 0.33
   • Paper Implications of Homologous Recombination Deficiency for Neoadjuvant Platinum-Based Chemotherapy in Pancreatic Cancer: A… DOI 10.1245/s10434-025-19056-0↗
4. Arsen Osipov · 1 shared paper, 2026 · strength 0.33
   • Paper Implications of Homologous Recombination Deficiency for Neoadjuvant Platinum-Based Chemotherapy in Pancreatic Cancer: A… DOI 10.1245/s10434-025-19056-0↗
5. David Tsai Ting · 1 shared paper, 2024 · strength 0.17
   • Paper Interplay between B7-H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2024.216713↗
6. Yurie Sekigami · 1 shared paper, 2024 · strength 0.17
   • Paper Interplay between B7-H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2024.216713↗
7. Cristina R. Ferrone · 1 shared paper, 2024 · strength 0.17
   • Paper Interplay between B7-H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2024.216713↗
8. Paul A. Moore · 1 shared paper, 2024 · strength 0.17
   • Paper Interplay between B7-H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2024.216713↗
9. Lei Cai · 1 shared paper, 2024 · strength 0.17
   • Paper Interplay between B7-H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2024.216713↗
10. Theodoros P. Michelakos · 1 shared paper, 2024 · strength 0.17
    • Paper Interplay between B7-H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2024.216713↗
11. Soldano Ferrone · 1 shared paper, 2024 · strength 0.17
    • Paper Interplay between B7-H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2024.216713↗
12. Xinhui Wang · 1 shared paper, 2024 · strength 0.17
    • Paper Interplay between B7-H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2024.216713↗
13. Vikram Deshpande · 1 shared paper, 2024 · strength 0.17
    • Paper Interplay between B7-H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2024.216713↗
14. Nabeel M. Bardeesy · 1 shared paper, 2024 · strength 0.17
    • Paper Interplay between B7-H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2024.216713↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.